Value Investing Research & Market Analysis

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVRx, Inc. - Common Stock (NQ:CVRX)

0.6668 -0.0332 (-4.74%)
Delayed Quote Updated: 10:28 AM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CVRx, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Top US Stock Gainers and Losers in Today's Session ↗
Via Chartmill
Top US Stock Gainers and Losers: Nov. 6, 2026 Session ↗
Via Chartmill
News headline image
CVRx (CVRX) Q3 2026 Earnings Call Transcript ↗
Payer delays and specialist turnover weighed on results and guidance. 
Via The Motley Fool
Topics Earnings
Gap Stocks in Today's Session ↗
Via Chartmill
CVRX Inc (NASDAQ:CVRX) Q1 2026 Earnings Meet Revenue Estimates, Loss Slightly Narrower Than Expected ↗
Via Chartmill
CVRX Inc (NASDAQ:CVRX) Reports Mixed Q4 2025 Results, Slight EPS Miss ↗
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
Top movers analysis one hour before the close of the markets on 2026-09-30: top gainers and losers in today's session. ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch. ↗
One of J&J's investments stands head-and-shoulders above the rest. 
Via The Motley Fool
News headline image
Earnings Scheduled For August 4, 2025 ↗
 
Via Benzinga
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
CVRx (CVRX) Q2 2026 Earnings Call Transcript ↗
U.S. heart failure revenue surged 21% amid reimbursement gains and sales expansion challenges. 
Via The Motley Fool
Topics Earnings
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
CVRx Eyes Barostim Growth as Coverage Gains and BENEFIT-HF Trial Launches ↗
CVRx (NASDAQ:CVRX) outlined its efforts to expand adoption of its Barostim therapy for heart failure patients, emphasizing sales-force execution, payer coverage progress and a large post-market... 
Via MarketBeat
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Which stocks are gapping on Friday? ↗
Via Chartmill
Top movers in Friday's pre-market session ↗
Via Chartmill
News headline image
CVRx Q2 Earnings Call Highlights ↗
CVRx (NASDAQ:CVRX) reported second-quarter revenue growth and an improved gross margin, but lowered its full-year outlook as sales-force turnover, slower productivity ramps and reimbursement challenges... 
Via MarketBeat
Topics Earnings
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
Via Chartmill
News headline image
CVRx Q1 Earnings Call Highlights ↗
CVRx (NASDAQ:CVRX) reported first-quarter 2026 revenue of $14.8 million, up 20% from the prior-year period, as U.S. growth in its Barostim heart failure business helped the company exceed the high end... 
Via MarketBeat
Topics Earnings
News headline image
CVRx (CVRX) Q1 2026 Earnings Call Transcript ↗
CVRx (CVRX) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
News headline image
CVRx (CVRX) Q4 2025 Earnings Call Transcript ↗
CVRx (CVRX) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
CVRx (CVRX) Q3 2025 Earnings Call Transcript ↗
CVRx (CVRX) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
CVRx (CVRX) Q2 Revenue Jumps 15% ↗
Via The Motley Fool
News headline image
CVRx Inc (NASDAQ:CVRX) Reports Q2 2025 Earnings: Revenue Slightly Beats Estimates While EPS Misses ↗
CVRx reported Q2 2025 revenue of $13.59M, beating estimates, but EPS missed at -$0.57. Shares dipped slightly as losses widened despite steady Barostim commercialization. 
Via Chartmill
News headline image
Top movers in Friday's session ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Friday's session. ↗
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.